There is no FDA-approved HPV test for men. Unlike cervical screening for women, no routine test exists to detect HPV infection in males who have no symptoms. The FDA has only approved HPV tests for use on cervical samples, and the CDC explicitly states these tests “are not useful for men of any age.” That doesn’t mean HPV goes completely undetected in men, but the path to diagnosis looks very different than most people expect.
Why There’s No Routine HPV Test for Men
HPV testing in women works because the cervix provides a reliable, consistent sampling site where precancerous changes develop in a predictable pattern. Men don’t have an equivalent. The virus can live on the penile shaft, the glans, the foreskin, the scrotum, the anus, or the throat, and sampling all of those areas reliably is a challenge researchers haven’t solved yet.
Research on penile swabs illustrates the problem. In one study of over 1,300 samples from 317 men, HPV DNA detection rates varied dramatically by site: 24% from the penile shaft, 28% from the foreskin, 17% from the scrotum, 16% from the glans, and just 6% from urine. A single swab from one location can easily miss an infection present elsewhere. No standardized sampling method has proven accurate enough for the FDA to approve it for clinical use.
How HPV Is Actually Diagnosed in Men
In practice, HPV in men is diagnosed when it causes something visible or detectable. The most common scenario is genital warts. Doctors diagnose these through a simple visual exam. The growths are typically flat, raised, or stalk-like and appear on the shaft of the penis, under the foreskin, on the scrotum, or around the anus. Most of the time, no lab test is needed. The CDC notes that “HPV testing is not recommended for anogenital wart diagnosis because test results are not confirmatory and do not guide genital wart management.”
If a lesion looks unusual (pigmented, hard, bleeding, ulcerated, or stuck to underlying tissue), your doctor may take a biopsy. A biopsy is also warranted if warts don’t respond to treatment, if the diagnosis is uncertain, or if you’re immunocompromised. But for typical-looking warts, visual identification is the standard.
Some providers have used a vinegar (acetic acid) test, where a 3% to 5% solution is applied to the skin to make HPV-affected areas turn white. The CDC does not recommend this for routine use because the results don’t change how the infection is managed, and the test produces a high rate of false positives.
Anal Cancer Screening for Higher-Risk Men
One area where active HPV-related screening does exist for men is anal cancer prevention. The American Society for Colposcopy and Cervical Pathology (ASCCP) now recommends anal screening for specific groups based on their cancer risk.
The highest-priority group includes men who have sex with men and transgender women living with HIV, who should begin screening at age 35. Men who have sex with men and transgender women without HIV should start at age 45. Men who have sex with women and are living with HIV should also begin at 45. Solid organ transplant recipients are recommended to start screening ten years after their transplant.
The screening itself involves anal cytology (sometimes called an anal Pap test), where cells are collected from the anal canal and examined for precancerous changes. A digital rectal exam is recommended at every screening visit to check for early cancers by touch. If the cytology results come back abnormal, you’re referred for high-resolution anoscopy, a procedure where a specialist examines the anal lining under magnification and can biopsy suspicious areas.
No Approved Test for Throat HPV
HPV-related throat cancer (oropharyngeal cancer) is now more common in men than cervical cancer is in women in the United States, which makes the lack of a screening test especially frustrating. MD Anderson Cancer Center confirms there is currently no approved screening test to detect HPV in the throat. Blood tests are being researched but aren’t available for clinical use. The practical reality is that throat HPV is typically discovered only when cancer symptoms appear, such as a persistent sore throat, difficulty swallowing, ear pain on one side, or a lump in the neck.
What Happens if You’re Exposed
If a partner tells you they have HPV, or you’re concerned about exposure, the honest answer is that there’s no test to confirm or rule out infection in men without symptoms. That can feel unsatisfying, but there’s a reason doctors don’t chase asymptomatic HPV in men: the immune system clears most infections on its own, and there’s no antiviral treatment to speed the process.
A study following 290 men over time found the median time to clearance of any HPV infection was about 5.9 months. Roughly 75% of men tested negative within 12 months of their initial positive result. The clearance timeline was similar regardless of whether the HPV type was high-risk or low-risk, and age didn’t significantly affect how long infections lasted.
That clearance rate is why the CDC’s guidance states that “subclinical genital HPV infection typically clears spontaneously” and that antiviral therapy isn’t recommended to eliminate the virus. Treatment is only directed at visible problems like warts or precancerous lesions.
What You Can Do Now
If you’re a man trying to figure out your HPV status, here’s what’s realistic. You can ask your doctor to examine any unusual bumps, warts, or skin changes on your genitals or around your anus. If you fall into a higher-risk group for anal cancer, you can request anal cytology screening. You can get the HPV vaccine if you’re 26 or younger (or up to 45 after discussing it with your doctor), which protects against the strains most likely to cause cancer and warts. And you can do regular self-checks of your genital area, mouth, and throat for anything new or persistent.
Clinical trials are currently investigating whether self-collected urine samples could reliably detect HPV in men by comparing urine results to physician-collected penile samples. If validated, a urine-based test could eventually fill the gap in male HPV screening, but it’s not yet available outside of research settings.